Synbiotic Health was formed in 2018 by four academic researchers at the University of Nebraska-Lincoln (UNL). In 2019, Tim Brummels became the Chief Executive Officer. Synbiotic Health’s flagship probiotic strain, iVS-1®, was discovered in the UNL research labs and was exclusively licensed to Synbiotic Health. The corporate headquarters and R&D Discovery laboratory are located on the Nebraska Innovation Campus in Lincoln, Nebraska. The founders of Synbiotic Health are committed to development of a portfolio of clinically proven probiotic strains that will improve quality of life and promote healthy aging and well-being.